Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Golimumab treatment for complicated uveitis.
Miserocchi E, Modorati G, Pontikaki I, Meroni P, Gerloni V. Miserocchi E, et al. Among authors: gerloni v. Clin Exp Rheumatol. 2013 Mar-Apr;31(2):320-1. Epub 2013 Jan 18. Clin Exp Rheumatol. 2013. PMID: 23331715 No abstract available.
Rituximab for uveitis.
Miserocchi E, Pontikaki I, Modorati G, Bandello F, Meroni PL, Gerloni V. Miserocchi E, et al. Among authors: gerloni v. Ophthalmology. 2011 Jan;118(1):223-4. doi: 10.1016/j.ophtha.2010.07.031. Ophthalmology. 2011. PMID: 21199719 No abstract available.
Long-term treatment with golimumab for severe uveitis.
Miserocchi E, Modorati G, Pontikaki I, Meroni PL, Gerloni V. Miserocchi E, et al. Among authors: gerloni v. Ocul Immunol Inflamm. 2014 Apr;22(2):90-5. doi: 10.3109/09273948.2013.844265. Epub 2013 Oct 21. Ocul Immunol Inflamm. 2014. PMID: 24143896
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.
Zannin ME, Birolo C, Gerloni VM, Miserocchi E, Pontikaki I, Paroli MP, Bracaglia C, Shardlow A, Parentin F, Cimaz R, Simonini G, Falcini F, Corona F, Viola S, De Marco R, Breda L, La Torre F, Vittadello F, Martini G, Zulian F. Zannin ME, et al. J Rheumatol. 2013 Jan;40(1):74-9. doi: 10.3899/jrheum.120583. Epub 2012 Nov 1. J Rheumatol. 2013. PMID: 23118110 Free article.
Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC).
Foeldvari I, Klotsche J, Simonini G, Edelsten C, Angeles-Han ST, Bangsgaard R, de Boer J, Brumm G, Torrent RB, Constantin T, DeLibero C, Diaz J, Gerloni VM, Guedes M, Heiligenhaus A, Kotaniemi K, Leinonen S, Minden K, Miranda V, Miserocchi E, Nielsen S, Niewerth M, Pontikaki I, de Vicuna CG, Zilhao C, Yeh S, Anton J. Foeldvari I, et al. Among authors: gerloni vm. Pediatr Rheumatol Online J. 2019 Oct 1;17(1):66. doi: 10.1186/s12969-019-0345-2. Pediatr Rheumatol Online J. 2019. PMID: 31575380 Free PMC article.
Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.
Favalli EG, Pontikaki I, Becciolini A, Biggioggero M, Ughi N, Romano M, Crotti C, Gattinara M, Gerloni V, Marchesoni A, Meroni PL. Favalli EG, et al. Among authors: gerloni v. Clin Rheumatol. 2017 Aug;36(8):1747-1755. doi: 10.1007/s10067-017-3712-8. Epub 2017 Jun 8. Clin Rheumatol. 2017. PMID: 28597133
108 results